IBDEI0Y5 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16858,1,4,0)
 ;;=4^707.25
 ;;^UTILITY(U,$J,358.3,16858,1,5,0)
 ;;=5^Pressure Ulcer,Unstagebl
 ;;^UTILITY(U,$J,358.3,16858,2)
 ;;=^336653
 ;;^UTILITY(U,$J,358.3,16859,0)
 ;;=707.20^^92^942^58
 ;;^UTILITY(U,$J,358.3,16859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16859,1,4,0)
 ;;=4^707.20
 ;;^UTILITY(U,$J,358.3,16859,1,5,0)
 ;;=5^Pressure Ulcer,Stage NOS
 ;;^UTILITY(U,$J,358.3,16859,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,16860,0)
 ;;=110.4^^92^942^77
 ;;^UTILITY(U,$J,358.3,16860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16860,1,4,0)
 ;;=4^110.4
 ;;^UTILITY(U,$J,358.3,16860,1,5,0)
 ;;=5^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,16860,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,16861,0)
 ;;=078.12^^92^942^45
 ;;^UTILITY(U,$J,358.3,16861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16861,1,4,0)
 ;;=4^078.12
 ;;^UTILITY(U,$J,358.3,16861,1,5,0)
 ;;=5^Plantar Wart
 ;;^UTILITY(U,$J,358.3,16861,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,16862,0)
 ;;=250.80^^92^942^24
 ;;^UTILITY(U,$J,358.3,16862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16862,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,16862,1,5,0)
 ;;=5^Diabetic Ulcer
 ;;^UTILITY(U,$J,358.3,16862,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,16863,0)
 ;;=695.10^^92^942^33
 ;;^UTILITY(U,$J,358.3,16863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16863,1,4,0)
 ;;=4^695.10
 ;;^UTILITY(U,$J,358.3,16863,1,5,0)
 ;;=5^Erythema Multiforme,Unspec
 ;;^UTILITY(U,$J,358.3,16863,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,16864,0)
 ;;=695.11^^92^942^32
 ;;^UTILITY(U,$J,358.3,16864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16864,1,4,0)
 ;;=4^695.11
 ;;^UTILITY(U,$J,358.3,16864,1,5,0)
 ;;=5^Erythema Multiforme,Minor
 ;;^UTILITY(U,$J,358.3,16864,2)
 ;;=^336634
 ;;^UTILITY(U,$J,358.3,16865,0)
 ;;=695.12^^92^942^31
 ;;^UTILITY(U,$J,358.3,16865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16865,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,16865,1,5,0)
 ;;=5^Erythema Multiforme,Major
 ;;^UTILITY(U,$J,358.3,16865,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,16866,0)
 ;;=695.13^^92^942^75
 ;;^UTILITY(U,$J,358.3,16866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16866,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,16866,1,5,0)
 ;;=5^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,16866,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,16867,0)
 ;;=695.14^^92^942^67
 ;;^UTILITY(U,$J,358.3,16867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16867,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,16867,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,16867,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,16868,0)
 ;;=695.15^^92^942^79
 ;;^UTILITY(U,$J,358.3,16868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16868,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,16868,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,16868,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,16869,0)
 ;;=695.19^^92^942^30
 ;;^UTILITY(U,$J,358.3,16869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16869,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,16869,1,5,0)
 ;;=5^Erythema Multiforme NEC
 ;;^UTILITY(U,$J,358.3,16869,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,16870,0)
 ;;=707.01^^92^942^49
 ;;^UTILITY(U,$J,358.3,16870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16870,1,4,0)
 ;;=4^707.01
 ;;^UTILITY(U,$J,358.3,16870,1,5,0)
 ;;=5^Pressure Ulcer,Elbow
 ;;^UTILITY(U,$J,358.3,16870,2)
 ;;=^336834
 ;;^UTILITY(U,$J,358.3,16871,0)
 ;;=707.02^^92^942^60
 ;;^UTILITY(U,$J,358.3,16871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16871,1,4,0)
 ;;=4^707.02
 ;;^UTILITY(U,$J,358.3,16871,1,5,0)
 ;;=5^Pressure Ulcer,Upper Back
 ;;^UTILITY(U,$J,358.3,16871,2)
 ;;=^336835
